Antimicrobial, Antibiofilm and Toxicological Assessment of Propolis

Detalhes bibliográficos
Autor(a) principal: Queiroga, Maria Cristina
Data de Publicação: 2023
Outros Autores: Laranjo, Marta, Andrade, Nara, Marques, Mariana, Costa, Ana Rodrigues, Antunes, Célia Maria
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10174/34966
https://doi.org/Queiroga, M.C., Laranjo, M., Andrade, N., Marques, M., Costa, A.R., Antunes, C.M. (2023). Antimicrobial, antibiofilm and toxicological assessment of propolis. Antibiotics 2023, 12, 347. https://doi.org/10.3390/antibiotics12020347
https://doi.org/10.3390/antibiotics12020347
Resumo: Antimicrobial resistance is a serious problem for the control of infections and infectious diseases. Propolis is a substance produced by honeybees with antimicrobial and antibiofilm properties. To consider propolis as an alternative to the use of antimicrobials for infection control, we assessed its antimicrobial and antibiofilm activities. To assess propolis for topical medical use, toxicological studies were also performed. A Portuguese 70% propolis ethanolic extract was chemically evaluated and studied for antimicrobial activity on staphylococcal field isolates (n = 137) and antibiofilm action (n = 45). Cell toxicological assessment was performed using keratinocytes and fibroblasts. Pinobanksin, chrysin, acacetin, apigenin, pinocembrin, and kaempferol-dimethyl-ether were detected. All 137 isolates were susceptible to 6.68 mg/mL or lower propolis concentration (80% isolates were susceptible to <1 mg/mL). The mean percentage of biofilm inhibition was 71%, and biofilm disruption was 88.5%. Propolis (<1 mg/mL) was well-tolerated by fibroblasts and moderately tolerated by keratinocytes. The combined antimicrobial and antibiofilm effect of propolis, together with its low toxicity to connective tissue and epithelial cells, suggests a good applicability for topical antibacterial treatment. Therefore, propolis seems to be a good alternative to antimicrobials for the treatment of infections with Staphylococcus spp. that deserves to be evaluated in vivo.
id RCAP_4bc511677f85702a6a8ee2360bdfbdd0
oai_identifier_str oai:dspace.uevora.pt:10174/34966
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Antimicrobial, Antibiofilm and Toxicological Assessment of PropolispropolisantimicrobialantibiofilmtoxicologicalStaphylococcusfibroblastkeratinocyteAntimicrobial resistance is a serious problem for the control of infections and infectious diseases. Propolis is a substance produced by honeybees with antimicrobial and antibiofilm properties. To consider propolis as an alternative to the use of antimicrobials for infection control, we assessed its antimicrobial and antibiofilm activities. To assess propolis for topical medical use, toxicological studies were also performed. A Portuguese 70% propolis ethanolic extract was chemically evaluated and studied for antimicrobial activity on staphylococcal field isolates (n = 137) and antibiofilm action (n = 45). Cell toxicological assessment was performed using keratinocytes and fibroblasts. Pinobanksin, chrysin, acacetin, apigenin, pinocembrin, and kaempferol-dimethyl-ether were detected. All 137 isolates were susceptible to 6.68 mg/mL or lower propolis concentration (80% isolates were susceptible to <1 mg/mL). The mean percentage of biofilm inhibition was 71%, and biofilm disruption was 88.5%. Propolis (<1 mg/mL) was well-tolerated by fibroblasts and moderately tolerated by keratinocytes. The combined antimicrobial and antibiofilm effect of propolis, together with its low toxicity to connective tissue and epithelial cells, suggests a good applicability for topical antibacterial treatment. Therefore, propolis seems to be a good alternative to antimicrobials for the treatment of infections with Staphylococcus spp. that deserves to be evaluated in vivo.Antibiotics2023-05-04T11:17:23Z2023-05-042023-02-08T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10174/34966https://doi.org/Queiroga, M.C., Laranjo, M., Andrade, N., Marques, M., Costa, A.R., Antunes, C.M. (2023). Antimicrobial, antibiofilm and toxicological assessment of propolis. Antibiotics 2023, 12, 347. https://doi.org/10.3390/antibiotics12020347https://doi.org/10.3390/antibiotics12020347http://hdl.handle.net/10174/34966https://doi.org/10.3390/antibiotics12020347engcrique@uevora.ptmlaranjo@uevora.ptndndacrc@uevora.ptcmma@uevora.pt384Queiroga, Maria CristinaLaranjo, MartaAndrade, NaraMarques, MarianaCosta, Ana RodriguesAntunes, Célia Mariainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-01-03T19:37:34Zoai:dspace.uevora.pt:10174/34966Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T01:23:14.445833Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Antimicrobial, Antibiofilm and Toxicological Assessment of Propolis
title Antimicrobial, Antibiofilm and Toxicological Assessment of Propolis
spellingShingle Antimicrobial, Antibiofilm and Toxicological Assessment of Propolis
Queiroga, Maria Cristina
propolis
antimicrobial
antibiofilm
toxicological
Staphylococcus
fibroblast
keratinocyte
title_short Antimicrobial, Antibiofilm and Toxicological Assessment of Propolis
title_full Antimicrobial, Antibiofilm and Toxicological Assessment of Propolis
title_fullStr Antimicrobial, Antibiofilm and Toxicological Assessment of Propolis
title_full_unstemmed Antimicrobial, Antibiofilm and Toxicological Assessment of Propolis
title_sort Antimicrobial, Antibiofilm and Toxicological Assessment of Propolis
author Queiroga, Maria Cristina
author_facet Queiroga, Maria Cristina
Laranjo, Marta
Andrade, Nara
Marques, Mariana
Costa, Ana Rodrigues
Antunes, Célia Maria
author_role author
author2 Laranjo, Marta
Andrade, Nara
Marques, Mariana
Costa, Ana Rodrigues
Antunes, Célia Maria
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Queiroga, Maria Cristina
Laranjo, Marta
Andrade, Nara
Marques, Mariana
Costa, Ana Rodrigues
Antunes, Célia Maria
dc.subject.por.fl_str_mv propolis
antimicrobial
antibiofilm
toxicological
Staphylococcus
fibroblast
keratinocyte
topic propolis
antimicrobial
antibiofilm
toxicological
Staphylococcus
fibroblast
keratinocyte
description Antimicrobial resistance is a serious problem for the control of infections and infectious diseases. Propolis is a substance produced by honeybees with antimicrobial and antibiofilm properties. To consider propolis as an alternative to the use of antimicrobials for infection control, we assessed its antimicrobial and antibiofilm activities. To assess propolis for topical medical use, toxicological studies were also performed. A Portuguese 70% propolis ethanolic extract was chemically evaluated and studied for antimicrobial activity on staphylococcal field isolates (n = 137) and antibiofilm action (n = 45). Cell toxicological assessment was performed using keratinocytes and fibroblasts. Pinobanksin, chrysin, acacetin, apigenin, pinocembrin, and kaempferol-dimethyl-ether were detected. All 137 isolates were susceptible to 6.68 mg/mL or lower propolis concentration (80% isolates were susceptible to <1 mg/mL). The mean percentage of biofilm inhibition was 71%, and biofilm disruption was 88.5%. Propolis (<1 mg/mL) was well-tolerated by fibroblasts and moderately tolerated by keratinocytes. The combined antimicrobial and antibiofilm effect of propolis, together with its low toxicity to connective tissue and epithelial cells, suggests a good applicability for topical antibacterial treatment. Therefore, propolis seems to be a good alternative to antimicrobials for the treatment of infections with Staphylococcus spp. that deserves to be evaluated in vivo.
publishDate 2023
dc.date.none.fl_str_mv 2023-05-04T11:17:23Z
2023-05-04
2023-02-08T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10174/34966
https://doi.org/Queiroga, M.C., Laranjo, M., Andrade, N., Marques, M., Costa, A.R., Antunes, C.M. (2023). Antimicrobial, antibiofilm and toxicological assessment of propolis. Antibiotics 2023, 12, 347. https://doi.org/10.3390/antibiotics12020347
https://doi.org/10.3390/antibiotics12020347
http://hdl.handle.net/10174/34966
https://doi.org/10.3390/antibiotics12020347
url http://hdl.handle.net/10174/34966
https://doi.org/Queiroga, M.C., Laranjo, M., Andrade, N., Marques, M., Costa, A.R., Antunes, C.M. (2023). Antimicrobial, antibiofilm and toxicological assessment of propolis. Antibiotics 2023, 12, 347. https://doi.org/10.3390/antibiotics12020347
https://doi.org/10.3390/antibiotics12020347
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv crique@uevora.pt
mlaranjo@uevora.pt
nd
nd
acrc@uevora.pt
cmma@uevora.pt
384
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Antibiotics
publisher.none.fl_str_mv Antibiotics
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136714867867648